Unveiling the Truth: How the US Exit from WHO and a CIA Investigation into COVID-19 Origins Implicates Trump and Funding Dynamics

by Chief Editor

Welcome, dear viewers, to “百年真相.” In a notable move in 2025, President Donald Trump, having resumed office, announced the U.S.’s exit from the World Health Organization (WHO) for a second time. This decision underscored long-standing criticisms and a fierce debate about the integrity and effectiveness of the WHO amid global health crises.

A History of Tensions

President Trump first announced America’s intention to leave the WHO in 2020. According to U.N. protocol, a year’s notice is required, along with continued financial obligations until withdrawal. However, in January 2021, President Biden reversed this decision, citing a need to mend relationships and improve global health coordination. This reversal was short-lived, as Trump again nullified the decision in 2025, during his term.

Rationales Behind the Exit

The reasons for the withdrawal, outlined in Trump’s executive order, include criticism of the WHO’s mismanagement of the COVID-19 pandemic originating in Wuhan, China, failure to implement necessary reforms, susceptibility to political influence, particularly from China, and arguments over unequal financial contributions relative to other member states.

Financial Disparities

The question of financial fairness looms large. Trump highlighted how the U.S. contributes 18% of WHO’s dues, a significant discrepancy compared to China’s share, despite its large population. This, according to critics, exacerbates inequality and undermines transparency within the organization.

Political Influence

Much of the tension revolves around alleged Chinese influence within the organization. Concerns were raised that the WHO endorsed information from Chinese officials without sufficient scrutiny, delaying global responses and undermining trust. Critics argue that doing so compromised the organization’s independence and overall efficacy.

Future Implications for Global Health Governance

The U.S. exit from WHO opens questions about the future of global health governance. Can the WHO reform sufficiently to regain the trust of key nations, or will alternate platforms emerge? The ramifications could influence how global health crises are managed in the future.

Possible Realignments

With the U.S. pulling out, the WHO may need to seek new financial and strategic partners. Some experts suggest a potential pivot towards increased funding from the European Union or Asian conglomerates, yet none are likely to fill the financial void left by the U.S. entirely.

Fatal Flaws or Opportunity for Reform?

The WHO’s current scenario might be a catalyst for much-needed reform. Under increased scrutiny and pressure, meaningful change could be sparked, potentially leading to a more transparent and equitable organization better equipped to handle global health emergencies.

Call to Action

As we look to the future of global health governance, questions linger about leadership, transparency, and accountability. What role can and should the U.S. play in reshaping these structures? Share your thoughts in the comments or explore more articles on related topics.

FAQ: Understanding the U.S. and WHO

  • Why did President Trump withdraw from the WHO?
    His administration cited issues of mismanagement, undue influence by China, and financial inequities.
  • How might the U.S. withdrawal impact global health?
    It could lead to a shift in how global health crises are managed and who leads these efforts, potentially impacting WHO’s effectiveness.
  • Can the WHO reform itself?
    This remains uncertain, though external pressure may drive substantial changes.

Stay informed on these critical issues by subscribing to our newsletter for the latest updates and in-depth analyses.

You may also like

Leave a Comment